A Monocentric, Single-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of the Topical Drug Acnase Creme in the Treatment of Acne Vulgaris I and II (ACNASE)

NCT00877409 Phase 3 UNKNOWN

The objective of this study is to establish the safety in use of the topical drug Acnase Creme and its effectiveness in treatment of acne grade I (comedones) and II (comedones, papules, pustules).

Details

Lead sponsor	Zurita Laboratorio Farmaceutico Ltda.
Phase	Phase 3
Status	UNKNOWN
Enrolment	80
Start date	2009-04
Completion	2009-07

Conditions

• Acne Vulgaris

Interventions

• Benzoyl Peroxide 5% and Sulphur 2%
• Vehicle of Acnase

Primary outcomes

• Average clinical development of target lesions of the groups for each experimental time. — 12 weeks

Countries

Brazil